While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.
Early on in their careers, two neurologists became involved in advocacy issues on behalf of neurology on a national, regional, and local level.
Dr. Harris, Dr. Burke, and Dr. Cook received the Philadelphia Top Doctor award. Dr. Kulandaivel has been named a Top Doctor Under 40.
Dr. Klein argues that physicians should be made aware if pharmacies switch a physician-prescribed product for a biosimilar.
This bill ensures that patients and physicians are made aware if the pharmacist substitutes a biosimilar product.
Fifteen members of the American Headache Society reviewed the existing literature and developed a standard procedure for nerve blocks.